1311 - Targeted Degradation of NF-κB RelA/p65 by PBD-Based PROTACs as a Novel Therapeutic Strategy in Chronic Lymphocytic Leukaemia

Primary Author / Presenter(s)

PJ

Peiqin Jin, PhD

School of Cancer and Pharmaceutical Sciences, King’s College London
London, England, United Kingdom
MH

Md. Mahbub Hasan, PhD

School of Cancer and Pharmaceutical Sciences, King’s College London
London, England, United Kingdom
Andrea Pepper, PhD

Brighton and Sussex Medical School
University of Sussex
Brighton, England, United Kingdom
SM

Simon Mitchell, PhD

Brighton and Sussex Medical School
Brighton, England, United Kingdom
KR

Khondaker Miraz Rahman, PhD

School of Cancer and Pharmaceutical Sciences, King’s College London
London, England, United Kingdom